Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer.

Autor: Schatz CA; Bayer AG, Berlin, Germany., Zitzmann-Kolbe S; Bayer AG, Berlin, Germany., Moen I; Bayer AS, Oslo, Norway., Klotz M; Bayer AG, Berlin, Germany., Nair S; Bayer AG, Berlin, Germany., Stargard S; Bayer AG, Berlin, Germany., Bjerke RM; Bayer AS, Oslo, Norway., Wickstrøm Biseth K; Bayer AS, Oslo, Norway., Feng YZ; Bayer AS, Oslo, Norway., Indrevoll B; Bayer AS, Oslo, Norway., Cruciani V; Bayer AS, Oslo, Norway., Karlsson J; Bayer AS, Oslo, Norway., Haendler B; Bayer AG, Berlin, Germany., Nielsen CH; Minerva Imaging, Oelstykke, Denmark., Alfsen MZ; Minerva Imaging, Oelstykke, Denmark., Hammer S; Bayer AG, Berlin, Germany., Hennekes H; Bayer AG, Berlin, Germany., Cuthbertson A; Bayer AS, Oslo, Norway., Hagemann UB; Bayer AG, Berlin, Germany., Larsen Å; Bayer AS, Oslo, Norway.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jun 03; Vol. 30 (11), pp. 2531-2544.